Protection of a Single Dose West Nile Virus Recombinant Subviral Particle Vaccine against Lineage 1 or 2 Strains and Analysis of the Cross-Reactivity with Usutu Virus

First evidence of simultaneous occurrence of West Nile virus and Usutu virus neuroinvasive disease in humans in Croatia during the 2013 outbreak

(2014) T. Vilibic-Cavlek et al.   INFECTION

A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available

(2014) Tomohiro Ishikawa et al.   VACCINE

Detection of specific antibodies against West Nile and Usutu viruses in healthy blood donors in northern Italy, 2010–2011

(2013) A. Pierro et al.   CLINICAL MICROBIOLOGY AND INFECTION

Outbreak of West Nile virus infection among humans in Serbia, August to October 2012

(2013) N Popović et al.   Eurosurveillance

Monitoring West Nile virus (WNV) infection in wild birds in Serbia during 2012: first isolation and characterisation of WNV strains from Serbia

(2013) T Petrović et al.   Eurosurveillance

West Nile Virus: Review of the Literature

(2013) Lyle R. Petersen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

An Inactivated Cell Culture Japanese Encephalitis Vaccine (JE-ADVAX) Formulated with Delta Inulin Adjuvant Provides Robust Heterologous Protection against West Nile Encephalitis via Cross-Protective Memory B Cells and Neutralizing Antibody

(2013) N. Petrovsky et al.   JOURNAL OF VIROLOGY

A Single Amino Acid Substitution in the Core Protein of West Nile Virus Increases Resistance to Acidotropic Compounds

(2013) Miguel A. Martín-Acebes et al.   PLoS One

Characterization of the Mouse Neuroinvasiveness of Selected European Strains of West Nile Virus

(2013) Stephanie M. Lim et al.   PLoS One

Protection of red-legged partridges (Alectoris rufa) against West Nile virus (WNV) infection after immunization with WNV recombinant envelope protein E (rE)

(2013) E. Escribano-Romero et al.   VACCINE

Inactivated West Nile Virus (WNV) vaccine, Duvaxyn WNV, protects against a highly neuroinvasive lineage 2 WNV strain in mice

(2013) Marietjie Venter et al.   VACCINE

Demonstration of Usutu Virus Antibodies in Horses, Croatia

(2013) Ljubo Barbic et al.   VECTOR-BORNE AND ZOONOTIC DISEASES

Explosive spread of a neuroinvasive lineage 2 West Nile virus in Central Europe, 2008/2009

(2013) Tamás Bakonyi et al.   VETERINARY MICROBIOLOGY

Vaccines in Development against West Nile Virus

(2013) Samantha Brandler et al.   Viruses-Basel

A Review of Vaccine Approaches for West Nile Virus

(2013) Arun Iyer et al.   International Journal of Environmental Research and Public Health

Infection with Usutu Virus Induces an Autophagic Response in Mammalian Cells

(2013) Ana-Belén Blázquez et al.   PLoS Neglected Tropical Diseases

Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex

(2012) Mario Lobigs et al.   Expert Review of Vaccines

Flaviviruses and their antigenic structure

(2012) F.X. Heinz et al.   JOURNAL OF CLINICAL VIROLOGY

Trends in vaccine adjuvants

(2011) Virgil EJC Schijns et al.   Expert Review of Vaccines

Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus

(2011) David WC Beasley   Immunotherapy

A West Nile virus mutant with increased resistance to acid-induced inactivation

(2011) M. A. Martin-Acebes et al.   JOURNAL OF GENERAL VIROLOGY

West Nile Virus Replication Requires Fatty Acid Synthesis but Is Independent on Phosphatidylinositol-4-Phosphate Lipids

(2011) Miguel A. Martín-Acebes et al.   PLoS One

Globalization, Land Use, and the Invasion of West Nile Virus

(2011) A. M. Kilpatrick   SCIENCE

Multiple amino acid changes at the first glycosylation motif in NS1 protein of West Nile virus are necessary for complete attenuation for mouse neuroinvasiveness

(2011) Melissa C. Whiteman et al.   VACCINE

Protection provided by a recombinant ALVAC®-WNV vaccine expressing the prM/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain

(2011) J.M. Minke et al.   VACCINE

First Serological Evidence of West Nile Virus Activity in Horses in Serbia

(2011) Diana Lupulovic et al.   VECTOR-BORNE AND ZOONOTIC DISEASES

Usutu Virus in Africa

(2011) Birgit Nikolay et al.   VECTOR-BORNE AND ZOONOTIC DISEASES

Usutu virus in ITALY: An emergence or a silent infection?

(2011) Giovanni Savini et al.   VETERINARY MICROBIOLOGY

False-Positive Transcription-Mediated Amplification Assay Detection of West Nile Virus in Blood from a Patient with Viremia Caused by an Usutu Virus Infection

(2010) P. Gaibani et al.   JOURNAL OF CLINICAL MICROBIOLOGY

A Single Amino Acid Substitution in the Capsid of Foot-and-Mouth Disease Virus Can Increase Acid Lability and Confer Resistance to Acid-Dependent Uncoating Inhibition

(2010) M. A. Martin-Acebes et al.   JOURNAL OF VIROLOGY

Immunogenicity and efficacy of two types of West Nile virus-like particles different in size and maturation as a second-generation vaccine candidate

(2010) Naohiro Ohtaki et al.   VACCINE

West Nile Virus Lineage 2 as a Cause of Zoonotic Neurological Disease in Humans and Horses in Southern Africa

(2010) Marietjie Venter et al.   VECTOR-BORNE AND ZOONOTIC DISEASES

Efficient Assembly and Secretion of Recombinant Subviral Particles of the Four Dengue Serotypes Using Native prM and E Proteins

(2009) Pei-Gang Wang et al.   PLoS One

Zoonotic mosquito-borne flaviviruses: Worldwide presence of agents with proven pathogenicity and potential candidates of future emerging diseases

(2009) H. Weissenböck et al.   VETERINARY MICROBIOLOGY

The Zoonotic Flaviviruses of Southern, South-Eastern and Eastern Asia, and Australasia: The Potential for Emergent Viruses

(2009) J. S. Mackenzie et al.   Zoonoses and Public Health

Live Chimeric and Inactivated Japanese Encephalitis Virus Vaccines Differ in Their Cross-Protective Values against Murray Valley Encephalitis Virus

(2008) M. Lobigs et al.   JOURNAL OF VIROLOGY